Search the Newsreel

LSV Asset Management (RNG) reports 3.98M-share beneficial stake in RingCentral

LSV Asset Management has disclosed a 5.37% beneficial stake in RingCentral, Inc. (RNG), totaling 3,977,000 shares of Class A Common Stock. The firm holds sole voting power over 2,186,600 shares and sole dispositive power over all 3,977,000 shares, with no shared powers. This filing, …

Concentra Group Holdings Parent, Inc. Announces Results For Its Second Quarter Ended June 30, 2026 and Raises FY 2026 Guidance

Matt DiCanio to become president and CEO and Keith Newton to transition to executive chairman, effective Nov. 1, 2026 DALLAS, August 06, 2026--(BUSINESS WIRE)--Concentra Group Holdings Parent, Inc. ("Concentra", the "Company", "we", "us", or "our") (NYSE: CON), the nation's largest provider of occupational health …

Central Bancompany (CBC) Stock Ignores Margin Strength As Valuation Questions Linger

Central Pacific Financial (NYSE: CPF) grows Q2 2026 earnings

CENTRAL GARDEN & PET CO 3Q 2026: Revenue $882.36M, EPS $1.45— 10-Q Summary

CENTRAL GARDEN & PET CO reported its third-quarter 2026 results, showing net sales of $882.36M and diluted EPS of $1.45. The company's revenue declined by 8.2% year-over-year due to a divestiture but saw organic sales growth of about 2.4% and improved operating margins. Key …

Earnings call transcript: ADENTRA beats Q2 2026 estimates, shares jump 8.5%

Central Puerto SA (CEPU) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Central Puerto SA (CEPU), detailing its current earnings forecast score, average price target of $17.65, and analyst ratings. Based on 4 analysts, the stock receives a "Strong Buy" recommendation with an anticipated 80.99% upside. Key financial forecasts …

Earnings Flash (CON) Concentra Group Holdings Parent, Inc. Posts Q2 Adjusted EPS $0.52 per Share, vs. FactSet Est of $0.42

Concentra Group Holdings Parent, Inc. reported Q2 adjusted EPS of $0.52 per share, surpassing the FactSet estimate of $0.42. The company also announced an increase in its 2026 revenue guidance, board changes, and the appointment of Matt DiCanio as CEO.

Entrada Therapeutics earnings beat by $0.04, revenue fell short of estimates

Central Garden & Pet Beats on Q3 Earnings, Raises FY26 EPS Outlook

Central Garden & Pet Company CENT reported third-quarter fiscal 2026 results, wherein the top and bottom lines beat the Zacks Consensus Estimate. Earnings declined year over year, while sales decreased due to the exit of the lower-margin pet distribution business. However, organic sales increased, …

Why ADENTRA Inc. stock is skyrocketing today

Central Garden & Pet Announces Q3 Fiscal 2026 Financial Results

Central Garden & Pet announced its Q3 Fiscal 2026 financial results, reporting a net sales decline of 8% but organic sales growth of 2%. The company delivered GAAP diluted EPS of $1.45 and non-GAAP EPS of $1.54, and subsequently raised its fiscal 2026 outlook …

Canaccord raises Central Garden & Pet stock price target on results

Canaccord has increased its price target for Central Garden & Pet Co. (NASDAQ:CENT) shares to $60 from $53, while maintaining a Buy rating, following the company's strong third-quarter results. Despite an 8% decline in net sales due to the exit of its pet distribution …

Nubz® Flavor Bursts Win “Flavored Dog Treat Product of the Year” in 2026 Pet Innovation Awards

Pet Innovation Awards This annual awards program recognizes companies, services, and products within the rapidly expanding Pet Care industry that exemplify excellence & innovation. LOS ANGELES, Aug. 06, 2026 (GLOBE NEWSWIRE) -- The 2026 Pet Innovation Awards today announced that Nubz® Flavor Bursts, an …

Nylabone Wins “Chew Toy Product of the Year” In 2026 Pet Innovation Awards

Pet Innovation Awards This annual awards program recognizes companies, services, and products within the rapidly expanding Pet Care Industry that exemplify excellence & innovation LOS ANGELES, Aug. 06, 2026 (GLOBE NEWSWIRE) -- The 2026 Pet Innovation Awards today announced that Nylabone, an iconic brand …

Kyntra Bio to host a live Q&A after Aug. 13 results

Kyntra Bio (Nasdaq: KYNB) will release its second quarter 2026 financial results on August 13, 2026, after market close, followed by a conference call and webcast at 5:00 PM Eastern Time. The company will discuss its financial performance and provide a business update, including …

Kyntra Bio to Report Second Quarter 2026 Financial Results

Kyntra Bio, Inc. (Nasdaq: KYNB) announced it will release its second quarter 2026 financial results on Thursday, August 13, after market close. The company will also host a conference call and webcast at 5:00 PM Eastern Time on the same day to discuss its …

Entrada Therapeutics Releases Q2 2026 Financial Results

Entrada Therapeutics, Inc. reported a net loss of $42.8 million for the first half of 2026, reflecting continued investment in its pipeline of intracellular therapeutics. The company posted a loss of $1.01 per share, with revenue totaling $898,000, a 54.0% decrease from H1 2025. …

Entrada Therapeutics, Inc. (TRDA) Stock Price, News, Quote & History

This page provides comprehensive financial data for Entrada Therapeutics, Inc. (TRDA), a clinical-stage biopharmaceutical company. It includes real-time stock price, historical data, key statistics, performance overview against the S&P 500, earnings trends, analyst insights, and valuation measures. The company focuses on developing genetic medicines …

Sentral REIT Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Natera president Solomon Moshkevich sells $905,626 in stock

Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold 3,410 shares of company stock worth $905,626 on August 3, 2026, with prices ranging from $259.98 to $268.6964 per share. These sales included shares to cover tax obligations from vested RSUs and shares sold …

Natera president John Fesko sells $79,056 in company stock.

Natera's President and Chief Business Officer, John Fesko, sold 295 shares of the company's stock worth $79,056 to cover tax obligations related to vested restricted stock units. The sale occurred while Natera's stock is near its 52-week high and has shown a 99% return …

Form 4 Natera Inc For: 6 August By Investing.com

This article reports on a Form 4 filing for Natera Inc. on August 6th. It mentions the company's stock symbol NTRA, which experienced a -3.65% change, and invites readers to view comments. The content is very brief and mostly consists of navigation and market …

Sentral Reit Announces Interim Gross Income Distribution for Period from 1 January 2026 to 30 June 2026, Payable on September 18, 2026

Intraco Limited Reports Earnings Results for the Half Year Ended June 30, 2026

Central Garden & Pet (NASDAQ:CENT) Sets New 12-Month High on Strong Earnings

Natera (NASDAQ: NTRA) lifts 2026 outlook on $753M Q2 revenue

[10-Q] Concentra Group Holdings Parent, Inc. Quarterly Earnings Report

Concentra Group Holdings Parent Inc (CON) is scheduled to release its Q2

Central Puerto (CEPU) Projected to Post Earnings on Thursday

Central Garden & Pet Co (CENT) (Q3 2026) Earnings Call Highlights: Organic Growth and ...

This article first appeared on GuruFocus. Net Sales: Declined 8% to $882 million, impacted by the exit of the Pet distribution business. Organic Net Sales: Rose 2% to $862 million, reflecting growth in both Garden and Pet segments. Non-GAAP Gross Profit: $318 million, down …

Will Algoma Central Corporation (ALC) Beat Estimates Again in Its Next Earnings Report?

Central Garden & Pet Company A (CENTA) shows split momentum before results

The consumer defensive stock has cooled in recent weekly returns, even as the longer lookback remains positive before earnings.

Natera executive (NASDAQ: NTRA) logs 3,410-share sale under Rule 10b5-1 plans

Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc. (NASDAQ: NTRA), sold a total of 3,410 shares of common stock on August 3, 2026. These sales, conducted under Rule 10b5-1 plans, included shares sold to cover tax withholding obligations on RSU vesting and additional …

Natera (NTRA) co-founder sells 109 shares to cover RSU-related taxes

Jonathan Sheena, co-founder and director of Natera, Inc. (NTRA), sold 109 shares of common stock on August 3, 2026, at a price of $267.9893 per share. This sale was conducted to fulfill tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs) …

Natera (NASDAQ: NTRA) CEO stock sales cover RSU taxes, 10b5-1 plan

Natera, Inc. CEO and President Steven Leonard Chapman sold a total of 3,076 shares of common stock on August 3, 2026. A portion of these sales, specifically 1,182 shares, was executed to cover tax withholding obligations related to the vesting of Restricted Stock Units …

Natera (NTRA) CFO logs 795-share stock sales for taxes and Rule 10b5-1

Natera's Chief Financial Officer, Michael Burkes Brophy, reported two sales of common stock totaling 795 shares. These sales, executed on August 3 and August 4, 2026, were made to cover tax obligations related to RSU vesting and through a Rule 10b5-1 trading plan. After …